
Camillo Ricordi
Chief and Professor, Cellular Transplantation · Jackson Memorial Hospital
Credentials: · ·
History
PresentCellular Transplantation Division · Jackson Memorial Hospital
- Present
Division of Cellular Transplantation · University of Miami/Jackson Health System
Internal Medicine

Research
International trial of the Edmonton protocol for islet transplantation
New England Journal of Medicine · 2006 · 1,516 citations
Automated method for isolation of human pancreatic islets
Diabetes · 1988 · First of 5 authors · 1,276 citations
The unique cytoarchitecture of human pancreatic islets has implications for islet cell function
Proceedings of the National Academy of Sciences of the United States of America · 2006 · 968 citations
- RA
178 papers
- AT
123 papers

54 papers · 16 as a fellow

50 papers
- GS
46 papers · 30 as a resident

46 papers

43 papers · 6 as a fellow
- TF
40 papers
Grants
- 2014–2019
Engineering a Human Physiomimetic Islet Microsystem
National Institute of Diabetes and Digestive and Kidney Diseases · UC4
PI · $4.9M · University of Florida
- 2008–2015
Ex Vivo Tolerance for Xenotransplantation of Diabetes P2
National Institute of Diabetes and Digestive and Kidney Diseases · R44
PI · $2M · Ximerex, Inc.
- 2009–2015
A Perfluorocarbon-Based Culture Device for Beta Cell Biology Applications (Phase
National Institute of Diabetes and Digestive and Kidney Diseases · R44
PI · $993.6K · Ophysio, Inc.
- 2004–2013
Strategies to Improve Long Term Islet Graft Survival
National Institute of Diabetes and Digestive and Kidney Diseases · U01
Contact PI · $11.6M · University of Miami School of Medicine
Clinical trials
- 2020
Use of UC-MSCs for COVID-19 Patients
Principal investigator · Completed · Phase 1, Phase 2
Camillo Ricordi
- 2011–2017
Extended Follow-Up After Islet Transplantation in T1D
Principal investigator · Completed
National Institute of Allergy and Infectious Diseases (NIAID)
- 2000–2004
Principal investigator · Completed · Phase 2
Rodolfo Alejandro
- 2006–2014
Strategies to Improve Islet Survival
Study chair · Completed · Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)

